Absorption of phenylbutazone from a paste formulation administered orally to the horse.
The absorption pattern of phenylbutazone was studied in five horses during administration of the drug in a paste formulation on days 1, 5, 8 and 12 of a 12-day dosing schedule. Since two or more plasma concentration peaks were usually obtained following each oral dose, it was concluded that phasic absorption was a particular feature of the oil:water formulation of the product. Possible causes of this unusual absorption pattern are discussed and the therapeutic implications of both phasic absorption and the recorded values of Cmax, tmax and AUC024 for phenylbutazone and its active metabolite oxyphenbutazone are considered.
D000042:Absorption; D000284:Administration, Oral; D000818:Animals; D001798:Blood Proteins / Q000032:analysis; D005260:Female; D006736:Horses / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D009824:Ointments; D010113:Oxyphenbutazone / Q000097:blood / Q000378:metabolism; D010653:Phenylbutazone / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*
D001798:Blood Proteins; D009824:Ointments; D010653:Phenylbutazone; D010113:Oxyphenbutazone